CD8A and neoplasm: Demaria and collaborators showed that intratumoral injection of exogenous cGAMP enhanced STING activation in the tumor microenvironment, resulting in stimulation of type I IFN response and antitumor CD8+ T cells, leading to growth inhibition of injected and contralateral tumors.